USD
$0.00
(0.00%
)At Close (As of Sep 16, 2025)
$2.34B
Market Cap
-
P/E Ratio
-3.47
EPS
$63.06
52 Week High
$7.58
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$130K |
Total Revenue | $0 |
Cost Of Revenue | $130K |
Costof Goods And Services Sold | $130K |
Operating Income | -$113M |
Selling General And Administrative | $9.1M |
Research And Development | $104M |
Operating Expenses | $113M |
Investment Income Net | - |
Net Interest Income | $1.5M |
Interest Income | $12M |
Interest Expense | $10M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $130K |
Income Before Tax | -$112M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$112M |
Comprehensive Income Net Of Tax | - |
Ebit | -$101M |
Ebitda | -$101M |
Net Income | -$112M |
Field | Value (USD) |
---|---|
Total Assets | $245M |
Total Current Assets | $245M |
Cash And Cash Equivalents At Carrying Value | $23M |
Cash And Short Term Investments | $23M |
Inventory | -$8.6M |
Current Net Receivables | $1.6M |
Total Non Current Assets | $552K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $213M |
Other Current Assets | $7.9M |
Other Non Current Assets | - |
Total Liabilities | $130M |
Total Current Liabilities | $32M |
Current Accounts Payable | $9.4M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $172K |
Total Non Current Liabilities | $98M |
Capital Lease Obligations | $226K |
Long Term Debt | $98M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $98M |
Other Current Liabilities | $22M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $116M |
Treasury Stock | - |
Retained Earnings | -$272M |
Common Stock | $37K |
Common Stock Shares Outstanding | $39M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$83M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $130K |
Capital Expenditures | $250K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$63M |
Cashflow From Financing | $138M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$112M |
Field | Value (USD) |
---|---|
Gross Profit | -$130K |
Total Revenue | $0 |
Cost Of Revenue | $130K |
Costof Goods And Services Sold | $130K |
Operating Income | -$113M |
Selling General And Administrative | $9.1M |
Research And Development | $104M |
Operating Expenses | $113M |
Investment Income Net | - |
Net Interest Income | $1.5M |
Interest Income | $12M |
Interest Expense | $10M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $130K |
Income Before Tax | -$112M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$112M |
Comprehensive Income Net Of Tax | - |
Ebit | -$101M |
Ebitda | -$101M |
Net Income | -$112M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. The company is headquartered in Minneapolis, Minnesota.